Savvoula Savvidou
2PUBLICATIONS
0CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Apr 07, 2026
Semaglutide-Induced Weight Loss Is the Main Determinant for the Improvement of Hepatic Biochemistry and Elastographic Repeated Measurements with FibroScan® in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease.Savvoula Savvidou, Elektra Augousti-Varela, Aikaterini Damianakou
|May 15, 2025
The role of mean platelet volume in metabolic dysfunction associated steatotic liver disease.Papagiouvanni Ioanna, Nervas Vasileios, Gouta Chrysoula
Pageof 1

